The goal of the treatment of Cushing's syndrome is rapid normalization of the negative metabolic effects and biochemical abnormalities associated with the disorder. Treatment is ultimately ...

Cushing disease treatment outcomes were improved among patients with normalized late-night salivary and mean urinary free cortisol levels.

The hypothesis is advanced that the cause of the potassium depletion and metabolic alkalosis of Cushing's syndrome is grossly exaggerated secretion of cortisol rather than oversecretion of ...

Over a decade into selling Korlym to treat endogenous hypercortisolism, also known as Cushing syndrome, Corcept Therapeutics ...

Cushing’s syndrome, a condition of chronic glucocorticoid excess, disrupts metabolic homeostasis, driving fat redistribution and promoting insulin resistance. New research uses a series of ...

Cushing's syndrome is a debilitating endocrine disorder ... causes significant morbidity and increased mortality due to its metabolic effects including hypertension, osteoporosis, obesity ...